4//SEC Filing
Wolf Jeffrey Alan 4
Accession 0001553350-22-000008
CIK 0001476963other
Filed
Jan 2, 7:00 PM ET
Accepted
Jan 3, 5:18 PM ET
Size
8.3 KB
Accession
0001553350-22-000008
Insider Transaction Report
Form 4
Wolf Jeffrey Alan
DirectorChief Executive Officer10% Owner
Transactions
- Other
Stock Option (right to buy)
2021-12-30−231,987→ 0 totalExercise: $4.07From: 2023-01-13Exp: 2031-12-12→ Common Stock (231,987 underlying) - Award
Stock Option (right to buy)
2021-12-30+231,987→ 231,987 totalExercise: $4.07From: 2023-12-30Exp: 2031-12-30→ Common Stock (231,987 underlying)
Footnotes (2)
- [F1]On December 28, 2021, the board of directors of Heat Biologics, Inc. (the "Company") rescinded and cancelled stock option awards previously made to Mr. Wolf on December 13, 2021 covering 231,987 shares under the Company's 2018 Stock Incentive Plan (the "Plan") and granted new stock options under the Plan, on substantially similar terms to the rescinded stock options, which new stock options are subject to forfeiture in the event an amendment to increase the number of shares of common stock available for grant under the Plan is not adopted by the Company's stockholders.
- [F2]The stock options to purchase 231,987 shares of Common Stock vest on the two-year anniversary of the date of grant, subject to the reporting person's continued service to the Company and is subject to forfeiture under certain circumstances.
Documents
Issuer
HEAT BIOLOGICS, INC.
CIK 0001476963
Entity typeother
Related Parties
1- filerCIK 0001381450
Filing Metadata
- Form type
- 4
- Filed
- Jan 2, 7:00 PM ET
- Accepted
- Jan 3, 5:18 PM ET
- Size
- 8.3 KB